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Objective: To evaluate the impact of standard fluid management on the effectiveness of ANH as a blood conservation
method in elective open AAA repair.
Design: Prospective randomised controlled study.
Methods: Thirty-four patients undergoing elective AAA repair were randomised to have ANH (16) or act as controls (18).
Intra-operative cell salvage was permitted in both groups. Haemoglobin (Hb) concentrations were determined at variable
intervals peri-operatively. Blood loss and the use of heterologous blood were recorded.
Results: The pre- and post-operative Hb concentrations, surgical blood loss and the use of cell salvage were similar in both
groups. Hb concentration (median, range) decreased significantly from pre-operative to aortic clamping (with blood loss
,100 ml) in ANH patients from 8.8 (7.5–10.2) to 5.7 (4.2–6.6) mmol/l following ANH but also in controls from 8.6 (7.5–
9.7) to 7.0 (4.5–9.0) mmol/l due to fluid infusion (P , 0.01 for every comparison). Bank blood requirements were similar:
median 2 units in ANH and 2.5 units in control patients (P ¼ 0.68).
Conclusions: Large volumes of fluids infused during AAA repair already conserve blood by the mechanism of
hypervolaemic haemodilution. When cell salvage is used with standard fluid management during AAA repair, additional
ANH is ineffective in saving blood.
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Introduction
Acute normovolaemic haemodilution (ANH, isovo-
laemic haemodilution) has been proposed as a useful
blood conservation method in major surgery, 1 – 6
including vascular surgery. 7,8 It involves withdrawal
of a certain amount of the patient’s blood prior to
blood loss and simultaneous replacement with the
same volume of non-cellular fluid. ANH is believed to
save blood by reducing the net intra-operative loss of
red blood cells and other blood constituents because
blood lost intraoperatively has a lower haematocrit as
a result of haemodilution. The ANH blood is retrans-
fused at completion of surgery.
Official guidelines recommend considering ANH as
part of planned perioperative blood management
when the expected blood loss is greater than 20% of
the circulating blood volume, or over 1000 ml, and the
preoperative haemoglobin is above 11.0 g/dl. 9 ANH
incurs minimal costs and can be performed by the
anaesthetist 5,10 but its clinical effectiveness remains
controversial. Most reports on ANH are observational
studies and have been criticised for poor design and
lack of randomisation. 2,11 The results of a recent meta-
analysis, which identified 28 prospective randomised
controlled trials out of 1573 studies on ANH, were
inconclusive due to substantial heterogeneity in the
methodology and results, such as small sample size,
different surgical procedures and variability in the
amount of blood withdrawn preoperatively. 11
This study focuses on a single procedure (AAA
repair) in which significant blood losses during
surgery can be anticipated. Following our previous
report of the advantageous effect of ANH on bank
blood use in AAA surgery, 12 this study evaluates the
blood saving efficiency of ANH comparing it to
standard fluid management in a randomised con-
trolled trial with cell salvage permitted in both groups.
We attempt to explain the negative results of this trial
in the discussion.
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Patients and Methods
Patients
Forty-seven consecutive patients undergoing elective
open AAA repair at the Bristol Royal Infirmary
between July 1998 and July 2000 were scrutinised
against entry criteria. The following exclusion criteria
were adopted: 2 – 4,6 pre-operative Hb , 7.4 mmol/l
(12.0 g/dl), moderate to severe left ventricular failure
with ejection fraction ,30%, poor exercise tolerance
(inability to walk 100 m and two flights of stairs),
severe ischaemic heart disease in the form of severe or
unstable angina and/or myocardial infarct within six
months, radiological evidence of critical stenosis of the
left main coronary artery, aortic stenosis, untreated
systemic hypertension, liver disease and coagulopa-
thy, impairment of renal function, sickle cell disease,
combined procedures and refusal to consent. Four
patients were excluded and seven did not consent.
Thirty-six patients were recruited, consented and
randomised into either the ANH or control group.
Randomisation was achieved using computer gener-
ated randomisation programme in blocks of four. The
study was not performed on the intention to treat basis
and patients who were randomised to have ANH but
did not have it were excluded. The study has been
granted ethical approval by the United Bristol
Healthcare Trust Research Ethics Committee.
Methods
ANH was performed in the anaesthetic room after
induction of general anaesthesia. Prior to the ANH
patients received 500–1000 ml of crystalloid solution
in order to restore normal hydration. Then 15 g/kg of
blood was removed via central line into the CPDA-1
collection bags containing citrate, phosphate, dextrose
and adenine (Baxter, UK), and simultaneously
replaced with similar volume of 6% medium
molecular weight hydroxyethyl starch (HAES). The
blood withdrawn was weighed and the amount
expressed in grams. For practical reasons the amount
of HAES used was rounded to 1000 or 1500 ml. Other
fluids were used as required during surgery. ANH
blood was retransfused intra-operatively if the trans-
fusion trigger was reached, or otherwise at completion
of surgery, and was never wasted. Fluids in the control
group were used as required. The same centrifugal cell
salvage devices (Haemonetics 4) producing red blood
cells concentrate of a known haematocrit of 55% were
set up intra-operatively in all patients but total
aspirates of less than 500–600 ml were considered
insufficient for centrifugation and the salvaged blood
was not processed in these circumstances. The triggers
for blood transfusion (autologous or heterologous) in
both groups, in the absence of clinical needs, were Hb
of 5.0 mmol/l (8.0 g/dl) intra-operatively and
5.9 mmol/l (9.5 g/dl) post-operatively. Other indi-
cations for intra-operative blood transfusion allowing
higher Hb concentrations were: signs of haemody-
namic instability or cardiac dysfunction (decrease in
systolic BP not responding to normovolaemia and
vasopressor agents or ischaemic changes on ECG),
sudden loss of a large amount of blood or uncontrol-
lable surgical bleeding. Autologous blood was used
first and followed by heterologous blood if further
transfusion was still necessary. The decision to
transfuse blood was taken between the anaesthetist,
surgeon and the investigator according to the above
protocol.
Haemoglobin concentration was measured in g/dl
but is also expressed in mmol/l to comply with the
International System of Units, using a conversion
factor of 0.6205. Haemoglobin concentrations were
determined in both groups (1) pre-operatively, (2) at
aortic clamping with blood loss not exceeding 100 ml,
(3) at clamp release, (4) within 1–2 h post-operatively,
(5) on the first, (6) second, (7) seventh post-operative
day and additionally in the ANH group at the end of
blood withdrawal. In three ANH and two control
patients in whom blood loss exceeded 100 ml before
aortic clamping, a blood sample for Hb was taken
when blood loss reached 100 ml but marked ‘at
clamping’ for clarity of data analysis. The volumes of
fluids infused intra-operatively, blood loss, volume
of RBCs saved and retransfused, and the amount of
heterologous blood used intra- and post-operatively
was also recorded. Blood loss was estimated using the
aspirates from the cell salvage device, sucker and from
weighing swabs and was expressed in millilitres of
total volume rather than net amount of RBCs.
Surgery was performed or supervised by one of three
vascular surgeons while general anaesthesia was carried
out by 16 different anaesthetists. Volatile agents and
epidural anaesthesia were used in all patients. Each
patient received a bolus of 5000 units of heparin
intravenously just prior to aortic cross-clamping.
The main investigator performed ANH. The use of
vasopressor agents and fluids other than ANH replace-
ment fluids were at the discretion of the anaesthetist.
Statistical analysis
Volumes of fluids, cell salvage, bank blood require-
ments, and some of the peri-operative Hb populations,
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were not normally distributed and, therefore, all data
were expressed uniformly as median (ranges) and
analysed using appropriate non-parametric tests.
Comparative analysis between the two groups was
performed using Mann–Whitney U-test. Hb changes
within each group (paired data) were analysed using
Wilcoxon signed rank sum test. Patients’ ages and
weights had near-normal distribution, non-parametric
and parametric tests yielded similar results but only
former test is quoted. Proportions were analysed by
Chi-square test or Fisher’s exact test. P ¼ 0:05 and
lower were considered statistically significant.
Results
Patients and aneurysms
Thirty-six patients were randomised equally into two
groups. Two patients randomised into the ANH group
exhibited signs of poor cardiac reserve, in the form of
hypotensive episodes in the presence of good central
venous filling, soon after induction of general anaes-
thesia, which precluded the ANH. Those two patients
were excluded from further analysis, leaving 16 ANH
and 18 control patients. Both groups were well
matched (Table 1). The incidence of ischaemic heart
disease in the form of previous myocardial infarction
or/and angina was similar: 5/16 ANH and 7/18
control patients. One patient randomised to the ANH
group had a successful coronary artery bypass graft
prior to AAA repair. All AAAs measured over 5.0 cm
in diameter and all were infra-renal but supra-renal
aortic clamping was necessary in 2 ANH and 3 control
patients (P ¼ 1:0; Fisher’s exact test).
ANH and retransfusion
Sixteen ANH patients underwent withdrawal of a
median amount of 890 (range 670–1620) g of blood,
excluding the weight of collection bags. The procedure
was well tolerated by all patients. Haemodynamic
instability or cardiac dysfunction was not observed
throughout surgery. In three patients part of the ANH
blood was retransfused before aortic clamping when the
Hb concentration decreased below transfusion trigger
from 7.9 (12.7) to 4.5 (7.3), 8.5 (13.7) to 4.7 (7.5) and 8.6
(13.8) to 4.8 (7.8) mmol/l (g/dl) with minimal blood loss
(less than 100 ml). ANH blood retransfusion was
required during clamping in seven patients, including
two patients in whom retransfusion had to be started
10 min after aortic clamping when Hb concentration
achieved 4.5 (7.3) and 4.7 (7.6) mmol/l (g/dl) but with
larger than 100 ml blood loss. In the remaining six
patients ANH blood retransfusion was commenced, as
intended, just before or after aortic clamp release, but in
one patient the clamp had to be reapplied.
Intra-operative fluids
By the time of ‘at clamping’ blood sample, a median
of 3500 ml of fluids (range 2000–4500 ml) consisting
of replacement fluids and additional fluids as
required was infused in the ANH group comparing
to 2000 ml (range 1000–3400 ml) in the control
group, which was statistically significant (P , 0:001;
Mann–Whitney U-test). But the total volumes of
fluids infused intra-operatively were similar: median
(range) 5000 (3000–9000) ml in the ANH group
comparing to 5000 (2500–15,000) ml in the control
group (P ¼ 0:72; Mann–Whitney U-test).
Surgical blood loss
The median (interquartile range) intra-operative blood
loss was 1780 (930–5000) ml in the ANH group and
1700 (750–2600) ml in the control group, and the
difference was not significant (Mann–Whitney U-test,
P ¼ 0:55). In four ANH and five control patients blood
loss was below 1000 ml (P ¼ 1:0; Fisher’s exact test).
Cell salvage
The median (interquartile range) volume of RBCs
concentrate recovered by intra-operative cell salvage
and retransfused was 590 (200–1410) ml in the ANH
group and 540 (210–740) ml in the control group, and
the difference was not significant (P ¼ 0:60; Mann–
Whitney U-test). In one ANH and two control patients
Table 1. Demographics on patients and aneurysms.
ANH group ðn ¼ 16Þ Control group ðn ¼ 18Þ Statistical test P value
Female:male ratio 6:10 5:13 Chi-square 0.99
Age; median (range) 72 (55–83) 76 (60–87) Mann–Whitney 0.09
Weight; median (range) 73 (45–108) 78 (57–105) Mann–Whitney 0.86
Grafts
Straight:bifurcated 10:6 12:6 Chi-square 1.0
Acute Normovolaemic Haemodilution in AAA Surgery 407
Eur J Vasc Endovasc Surg Vol 26, October 2003
the aspirate was insufficient for further processing and
no RBCs concentrate was retransfused, those patients
did no require blood transfusion peri-operatively.
Peri-operative Hb
The pre-operative Hb concentrations in the ANH and
control group were similar (Table 2). The Hb concen-
tration in the ANH group decreased significantly as a
result of the ANH comparing to the pre-op values, and
due to additional fluids infusion dropped further by
the aortic cross-clamping with minimal blood loss (less
than 100 ml). In the control group, as a result of
standard fluid infusion the Hb concentration also
decreased significantly by the aortic cross-clamping
with minimal blood loss (less than 100 ml) comparing
to the pre-operative values but not as much as in the
ANH group at the corresponding time point. The Hb
concentrations at clamp release were significantly
lower in the ANH group. The Hb concentrations
determined within 1–2 h post-operatively (once all
autologous blood has been transfused), on the first and
second post-operative day were similar in the two
groups but ANH patients had higher haemoglobin on
day seven post-operatively.
Use of heterologous blood
The use of bank blood was similar between the two
groups. In total peri-operatively, 10 ANH patients
required a median (interquartile range) of 3.5 (2–7)
units versus 13 controls who required 3 (2–6) units of
bank blood. Detailed statistical analysis is presented in
Table 3. In all patients who received heterologous
blood, relevant intra- or post-operative transfusion
triggers were achieved, except for two controls in
whom bank blood transfusion was indicated intra-
operatively for haemodynamic instability.
Discussion
The main finding of this study was no demonstrable
blood saving benefit when ANH was used in
combination with cell salvage. Noticeably, the haemo-
globin concentration was found to be higher in the
ANH patients on the seventh post-operative day,
although there were no statistical differences between
the groups immediately after surgery and within the
first two days post-operatively. This may suggest that
ANH did save some blood but the savings were small
and difficult to demonstrate. Some ANH enthusiasts
have concluded that greater than moderate haemodi-
lution does save some blood in every patient but the
savings are modest and smaller than one unit of bank
blood. 6,10 Although the sample size in the present
pilot study was small, close monitoring of intra-
operative fluids and haemoglobin allowed identifi-
cation of important factors limiting the effectiveness of
ANH in major vascular surgery.
The efficiency of ANH increases with: (1) higher
initial haematocrit, (2) larger circulating blood volume,
(3) greater amount of blood removed during the
haemodilution process, and (4) larger volume of
blood loss. 13,14 Large volumes of blood were removed
at the ANH in the present study to ensure significant
impact on bank blood requirements but necessitating
Table 2. Peri-operative Hb concentrations.
Hb concentration median (range) ANH group (n ¼ 16) Control group (n ¼ 18) P value Mann–Whitney
Pre-operative (mmol/l) 8.8 (7.5–10.2)† 8.6 (7.5–9.7)‡ 0.57
(g/dl) 14.2 (12.1–16.5) 13.8 (12.1–15.6)
Post-ANH 5.8 (4.3–7.5)†,§ – –
9.4 (7.0–12.1)
At aortic clamping 5.7 (4.2–6.6)§ 7.0 (4.5–9.0)‡ 0.001*
9.2 (6.8–10.6) 11.3 (7.2–14.5)
At clamp release 4.8 (4.1–5.8) 5.6 (3.2–7.4) 0.004*
7.7 (6.6–9.3) 9.1 (5.1–11.9)
Post-op 1–2 h 6.7 (5.5–8.3) 6.4 (5.0–7.9) 0.68
10.8 (8.8–13.3) 10.3 (8.1–12.7)
Post-op day 1 6.5 (5.2–7.7) 6.5 (5.1–7.9) 0.68
10.4 (8.3–12.4) 10.4 (8.2–12.8)
Post-op day 2 6.6 (5.1–8.3) 6.0 (5.3–8.5) 0.60
10.6 (8.2–13.3) 9.7 (8.5–13.7)
Post-op day 7 7.1 (6.3–7.7) 6.6 (5.6–7.4) 0.021*
11.5 (10.2–12.4) 10.7 (9.1–11.9)
*Statistically significant P value.
†P , 0:001 (Wilcoxon test).
‡P , 0:001 (Wilcoxon test).
§P ¼ 0:043 (Wilcoxon test).
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early retransfusion of some of the ANH blood in five
patients, in whom Hb concentration decreased below
the transfusion trigger even before or soon after aortic
clamping with minimal blood loss. Yet this degree of
haemodilution is regarded by standard definitions
as only moderate. 1,4,15,16 Computer models of ANH
predict 13,14,17 and even protagonists of ANH admit 18
that blood savings achieved by mild and moderate
degrees of haemodilution are small. Greater degrees of
haemodilution and lower transfusion triggers would
increase the efficiency of ANH, but were considered by
authors of the present study as undesirable and
dangerous for routine use in respect to both the type
of surgery (major haemodynamic changes demanding
effective adaptation of cardiovascular and oxygen
delivery systems) and the patient (elderly population
with high incidence of cardiac comorbidities),
although may be applicable in selected fit patients.
The transfusion trigger in the post-operative period
was set at a higher Hb than intra-operatively because
of increased oxygen consumption by an alert patient
and inability to monitor and adjust cardio-respiratory
function in the post-operative care as closely as during
anaesthesia. 15 A minimum safe Hct of 28% has been
recommended for post-operative care in high-risk
vascular patients to reduce the incidence of cardio-
vascular complications. 19,20
Another important factor compromising the effec-
tiveness of ANH in patients undergoing AAA surgery
is standard fluid management. Unlike in other surgical
procedures, where normovolaemia can be maintained,
anaesthesia during AAA repair requires infusion of
large volumes of fluids in order to counteract the
vasodilatory effects of epidural and other anaesthetic
agents, haemodynamic instability caused by aortic
cross-clamping and clamp release, as well as surgical
blood loss, which may be sudden and uncontrollable.
Good central venous filling is, therefore, required
throughout surgery but particularly at the aortic clamp
release. Haemodilution with fluids is an important
cause, next to blood loss, of the intra-operative drop in
the Hb concentration, which decreased significantly
also in control patients from pre-operatively to aortic
clamping by a median of 1.6 mmol/l (2.5 g/dl) even
before major blood loss occurred. Hypervolaemic
haemodilution per se has been previously recognised
as an efficient blood conservation method 21 and found
to be a simple and equally effective alternative to ANH
in hip replacement surgery. 22 The strategy of infusing
fluids much in excess of intra-operative fluid losses in
both ANH and control patients was, with some
variation, used by all anaesthetists involved in the
present study. This may have effected the decision
to transfuse blood and ultimately minimised any
potential effect of the ANH.
Intra-operative cell salvage itself may also diminish
the impact of ANH on the requirements for heter-
ologous blood transfusion by recovering some of the
haemorrhaged red blood cells, which would otherwise
be lost. The mechanism of action of ANH in reducing
the need for bank blood is by reducing the concen-
tration of RBC’s lost in the haemodiluted blood. The
authors elected to use cell salvage in both groups
because, like others, 23,24 we believe that it is an
efficient blood conservation method and we use it
routinely in major vascular procedures. The absolute
volumes of blood loss and the amounts of RBCs
concentrate achieved by the cell salvage did not differ
between the two groups. This finding was consistent
with similar requirements for heterologus blood and
may be explained by hypervolaemic haemodilution of
the control patients.
It has been suggested that peri-operative blood
conservation is most efficient when different methods
are used in combination, although not every strategy is
suitable for every type of surgery or patient. 2,4,25
Observational studies on elective open AAA repair
showed that most patients can avoid heterologous
blood transfusion, which was required in 29 out of 78
patients when ANH was used in combination with
intra-operative cell salvage 26 or in only 4 out of 13
Table 3. Use of heterologous blood.
Bank blood (units) ANH group (n ¼ 16) Control group (n ¼ 18) Statistical test P value
Intra-op
Median (interquartile range) 0 (0–4) 0 (0–2) Mann–Whitney 0.51
Avoided bank blood 9 11 Chi-square 1.00
Post-op
Median (interquartile range) 0 (0–2) 1 (0–2) Mann–Whitney 0.33
Avoided bank blood 11 8 Chi-square 0.73
In total peri-op
Median (interquartile range) 2 (0–5) 2.5 (0–5) Mann–Whitney 0.68
Avoided bank blood 6 5 Chi-square 0.99
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patients when autologous predonation was added. 27
Relevant multicentre randomised controlled trials in
abdominal aortic surgery (patients mix including
AAA repair and reconstruction for occlusive disease)
demonstrated significant reduction in the use of
heterologous blood transfusion in the autologous
group (ANH combined with intra-operative cell
salvage) when compared to the heterologous blood
only group. Bank blood transfusion was required in
43% versus 56% in one trial 28 and median (inter-
quartile range) of 0 (0–2) versus 2 (0–4) units of bank
blood was transfused in another series. 29 But the
significance of ANH cannot be ascertained from the
above study design. The present trial addressed this
question by permitting cell salvage in both groups.
Based on the negative results, we put forward the
hypothesis that the contribution of ANH to saving
blood, when used in combination with cell salvage
during AAA repair, is clinically insignificant and adds
no advantage over and above cell salvage alone. This
disappointing finding is consistent with recently
published results from a randomised controlled trial
of a similar design in cardiac surgery, in which ANH
added no blood saving benefit to aprotinin and intra-
operative cell salvage. 30 Our previous experience 12
suggested that ANH can be used efficiently by a
dedicated anaesthetist/surgeon team in selected cases
of AAA repair. The present randomised controlled
trial is a pilot study but the results do not support
routine use of ANH in AAA surgery. In view of the
anxieties that ANH of more than moderate degree
may produce myocardial ischaemia and impair
cardiac function 31 especially in the presence of
significant coronary artery disease, 32 which exists in
a high proportion of AAA patients, 33 cell salvage
alone seems the better alternative for routine use in
this particular patient population. ANH may yet be
effective in other types of surgery, in which excessive
fluid infusion can be avoided, or in selected patients
undergoing AAA repair especially if cell salvage is not
available.
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